Global Research Antibodies Market Size study, by Product (Reagents, Antibodies), by Technology, by Application (Proteomics, Drug Development, Genomics), by End User and by Regional Forecasts 2018-2025
Global Research Antibodies Market to reach USD 4.6 billion by 2025.
Global Research Antibodies Market valued approximately USD 2.64 billion in 2016 is anticipated to grow with a healthy growth rate of more than 6.30 % over the forecast period 2017-2025.
The market is predominantly driven by growing number of R&D collaborations among various public and private organizations to promote technical advancements in product development activities and disease progression studies. Consistent recommendations and guidelines issued by regulatory organizations for laboratories to facilitate generation of accurate results and ensure high-quality standards are slated to enhance adoption of research antibodies over the coming years. For instance, in May 2016, the International Society for Stem Cell Research issued revised guidelines for cell-based therapies. The revised guidelines were issued with a focus to improve overall efficiency and quality of preclinical studies increasing prevalence of cancer and other chronic diseases is encouraging academic institutes as well as pharmaceutical and biotechnology companies to develop advanced generation therapeutics and personalized medicines. This is one of the key trends stimulating market growth. Usage of research antibodies in early detection of cancer has also been gaining recognition in the medical industry. Asia-Pacific and the increasing demand for personalized medicine and protein therapeutics are expected to offer significant growth opportunities for players in this market.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Historical year – 2015, 2016
Base year – 2017
Forecast period – 2018 to 2025
The industry is seeming to be fairly competitive. Some of the leading market players include Merck Group, Abcam PLC, Becton, Dickinson and Company, Cell Signaling Technology, Inc, Bio-Rad Laboratories, Inc., Lonza, Genscript, Biolegend, Inc., Danaher Corporation, Thermo Fisher Scientific Inc and so on. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.
Target Audience of the Global Research Antibodies Market in Market Study:
Global Research Antibodies Market valued approximately USD 2.64 billion in 2016 is anticipated to grow with a healthy growth rate of more than 6.30 % over the forecast period 2017-2025.
The market is predominantly driven by growing number of R&D collaborations among various public and private organizations to promote technical advancements in product development activities and disease progression studies. Consistent recommendations and guidelines issued by regulatory organizations for laboratories to facilitate generation of accurate results and ensure high-quality standards are slated to enhance adoption of research antibodies over the coming years. For instance, in May 2016, the International Society for Stem Cell Research issued revised guidelines for cell-based therapies. The revised guidelines were issued with a focus to improve overall efficiency and quality of preclinical studies increasing prevalence of cancer and other chronic diseases is encouraging academic institutes as well as pharmaceutical and biotechnology companies to develop advanced generation therapeutics and personalized medicines. This is one of the key trends stimulating market growth. Usage of research antibodies in early detection of cancer has also been gaining recognition in the medical industry. Asia-Pacific and the increasing demand for personalized medicine and protein therapeutics are expected to offer significant growth opportunities for players in this market.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
- Reagents
- Antibodies
- Western Blotting
- Flow Cytometry
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Immunohistochemistry
- Immunofluorescence
- Immunoprecipitation
- Proteomics
- Drug Development
- Genomics
- Others
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Contract Research Organizations
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia Pacific
- China
- India
- Japan
- Latin America
- Brazil
- Mexico
- Rest of the World
Historical year – 2015, 2016
Base year – 2017
Forecast period – 2018 to 2025
The industry is seeming to be fairly competitive. Some of the leading market players include Merck Group, Abcam PLC, Becton, Dickinson and Company, Cell Signaling Technology, Inc, Bio-Rad Laboratories, Inc., Lonza, Genscript, Biolegend, Inc., Danaher Corporation, Thermo Fisher Scientific Inc and so on. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.
Target Audience of the Global Research Antibodies Market in Market Study:
- Key Consulting Companies & Advisors
- Large, medium-sized, and small enterprises
- Venture capitalists
- Value-Added Resellers (VARs)
- Third-party knowledge providers
- Investment bankers
- Investors
CHAPTER 1. GLOBAL RESEARCH ANTIBODIES MARKET DEFINITION AND SCOPE
1.1. Research Objective
1.2. Market Definition
1.3. Scope of The Study
1.4. Years Considered for The Study
1.5. Currency Conversion Rates
1.6. Report Limitation
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Data Mining
2.1.2. Analysis
2.1.3. Market Estimation
2.1.4. Validation
2.1.5. Publishing
2.2. Research Assumption
CHAPTER 3. EXECUTIVE SUMMARY
3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
3.2. Key Trends
CHAPTER 4. GLOBAL RESEARCH ANTIBODIES MARKET DYNAMICS
4.1. Growth Prospects
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.2. Industry Analysis
4.2.1. Porter’s 5 Force Model
4.2.2. PEST Analysis
4.2.3. Value Chain Analysis
4.3. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL RESEARCH ANTIBODIES MARKET, BY PRODUCT
5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. Global Research Antibodies Market, Sub Segment Analysis
5.3.1. Reagents
5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.2. Antibodies
5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 6. GLOBAL RESEARCH ANTIBODIES MARKET, BY TECHNOLOGY
6.1. Market Snapshot
6.2. Market Performance - Potential Model
6.3. Global Research Antibodies Market, Sub Segment Analysis
6.3.1. Western Blotting
6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.2. Flow Cytometry
6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.3. Enzyme-Linked Immunosorbent Assay (ELISA)
6.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.4. Immunohistochemistry
6.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.5. Immunofluorescence
6.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.6. Immunoprecipitation
6.3.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 7. GLOBAL RESEARCH ANTIBODIES MARKET, BY APPLICATION
7.1. Market Snapshot
7.2. Market Performance - Potential Model
7.3. Global Research Antibodies Market, Sub Segment Analysis
7.3.1. Proteomics
7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.2. Drug Development
7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.3. Genomics
7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 8. GLOBAL RESEARCH ANTIBODIES MARKET, BY END USER
8.1. Market Snapshot
8.2. Market Performance - Potential Model
8.3. Global Research Antibodies Market, Sub Segment Analysis
8.3.1. Pharmaceutical and Biotechnology Companies
8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.2. Academic and Research Institutes
8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.3. Contract Research Organizations
8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 9. GLOBAL RESEARCH ANTIBODIES MARKET, BY REGIONAL ANALYSIS
9.1. Research Antibodies Market, Regional Market Snapshot (2015-2025)
9.2. North America Research Antibodies Market Snapshot
9.2.1. U.S.
9.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2. Canada
9.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3. Europe Research Antibodies Market Snapshot
9.3.1. U.K.
9.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2. Germany
9.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3. France
9.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.4. Rest of Europe
9.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.4.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.4.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.4.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.4.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4. Asia Research Antibodies Market Snapshot
9.4.1. China
9.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2. India
9.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3. Japan
9.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4. Rest of Asia Pacific
9.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5. Latin America Research Antibodies Market Snapshot
9.5.1. Brazil
9.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2. Mexico
9.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6. Rest of The World
9.6.1. South America
9.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.6.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.1.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.2. Middle East and Africa
9.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.6.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.2.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Company Market Share (Subject to Data Availability)
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Thermo Fisher Scientific Inc.
10.3.1.1. Abcam PLC
10.3.1.2. Financial (Subject to Data Availability)
10.3.1.3. Product Summary
10.3.1.4. Recent Developments
10.3.2. Merck Group
10.3.3. Abcam PLC
10.3.4. Becton, Dickinson and Company
10.3.5. Cell Signaling Technology, Inc
10.3.6. Bio-Rad Laboratories, Inc.
10.3.7. Lonza
10.3.8. Genscript
10.3.9. Biolegend, Inc.
10.3.10. Danaher Corporation
1.1. Research Objective
1.2. Market Definition
1.3. Scope of The Study
1.4. Years Considered for The Study
1.5. Currency Conversion Rates
1.6. Report Limitation
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Data Mining
2.1.2. Analysis
2.1.3. Market Estimation
2.1.4. Validation
2.1.5. Publishing
2.2. Research Assumption
CHAPTER 3. EXECUTIVE SUMMARY
3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
3.2. Key Trends
CHAPTER 4. GLOBAL RESEARCH ANTIBODIES MARKET DYNAMICS
4.1. Growth Prospects
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.2. Industry Analysis
4.2.1. Porter’s 5 Force Model
4.2.2. PEST Analysis
4.2.3. Value Chain Analysis
4.3. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL RESEARCH ANTIBODIES MARKET, BY PRODUCT
5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. Global Research Antibodies Market, Sub Segment Analysis
5.3.1. Reagents
5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.2. Antibodies
5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 6. GLOBAL RESEARCH ANTIBODIES MARKET, BY TECHNOLOGY
6.1. Market Snapshot
6.2. Market Performance - Potential Model
6.3. Global Research Antibodies Market, Sub Segment Analysis
6.3.1. Western Blotting
6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.2. Flow Cytometry
6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.3. Enzyme-Linked Immunosorbent Assay (ELISA)
6.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.4. Immunohistochemistry
6.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.5. Immunofluorescence
6.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.6. Immunoprecipitation
6.3.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 7. GLOBAL RESEARCH ANTIBODIES MARKET, BY APPLICATION
7.1. Market Snapshot
7.2. Market Performance - Potential Model
7.3. Global Research Antibodies Market, Sub Segment Analysis
7.3.1. Proteomics
7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.2. Drug Development
7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.3. Genomics
7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 8. GLOBAL RESEARCH ANTIBODIES MARKET, BY END USER
8.1. Market Snapshot
8.2. Market Performance - Potential Model
8.3. Global Research Antibodies Market, Sub Segment Analysis
8.3.1. Pharmaceutical and Biotechnology Companies
8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.2. Academic and Research Institutes
8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.3. Contract Research Organizations
8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 9. GLOBAL RESEARCH ANTIBODIES MARKET, BY REGIONAL ANALYSIS
9.1. Research Antibodies Market, Regional Market Snapshot (2015-2025)
9.2. North America Research Antibodies Market Snapshot
9.2.1. U.S.
9.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2. Canada
9.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3. Europe Research Antibodies Market Snapshot
9.3.1. U.K.
9.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2. Germany
9.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3. France
9.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.4. Rest of Europe
9.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.4.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.4.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.4.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.4.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4. Asia Research Antibodies Market Snapshot
9.4.1. China
9.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2. India
9.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3. Japan
9.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4. Rest of Asia Pacific
9.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5. Latin America Research Antibodies Market Snapshot
9.5.1. Brazil
9.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2. Mexico
9.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6. Rest of The World
9.6.1. South America
9.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.6.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.1.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.2. Middle East and Africa
9.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.6.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.2.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Company Market Share (Subject to Data Availability)
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Thermo Fisher Scientific Inc.
10.3.1.1. Abcam PLC
10.3.1.2. Financial (Subject to Data Availability)
10.3.1.3. Product Summary
10.3.1.4. Recent Developments
10.3.2. Merck Group
10.3.3. Abcam PLC
10.3.4. Becton, Dickinson and Company
10.3.5. Cell Signaling Technology, Inc
10.3.6. Bio-Rad Laboratories, Inc.
10.3.7. Lonza
10.3.8. Genscript
10.3.9. Biolegend, Inc.
10.3.10. Danaher Corporation
